Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 16 - Issue 12 - December 2019

Insights

Clinical Trial Update
Two-Year Results of IMPERIAL: First-Ever Randomized Study of Eluvia and Zilver PTX in Femoropopliteal Artery Lesions
12/09/2019
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
Vascular Disease Management...
12/09/2019
Vascular Disease Management
Rapid Communication
​​​​​​​Lower Paclitaxel Dose, Smaller Delivery Platform: 12-Month Data From the RANGER SFA II Trial
11/12/2019
Vascular Disease Management talks with Ravish Sachar, MD, FACC, University of North Carolina - Rex Hospital Physician-in-Chief for Heart and Vascular Services, and Principal Investigator of the RANGER II SFA trial.
Vascular Disease Management talks with Ravish Sachar, MD, FACC, University of North Carolina - Rex Hospital Physician-in-Chief for Heart and Vascular Services, and Principal Investigator of the RANGER II SFA trial.
Vascular Disease Management...
11/12/2019
Vascular Disease Management
Tips and Techniques
Understanding the Tibial-Pedal Arterial Anatomy: Practical Points for Current Clinical Presentations
12/04/2019
Alexandrescu and colleagues review the main anatomical features describing infra-popliteal arterial vasculature with, and without, ischemic impairment, in accordance with practical clinical issues encountered in daily practice.
Alexandrescu and colleagues review the main anatomical features describing infra-popliteal arterial vasculature with, and without, ischemic impairment, in accordance with practical clinical issues encountered in daily practice.
Alexandrescu and colleagues...
12/04/2019
Vascular Disease Management
Endovascular Techniques
Defining Critical Limb Ischemia
12/04/2019
Parikh and colleagues discuss the recently released Global Vascular Guidelines and important new concepts emanating from these guidelines.
Parikh and colleagues discuss the recently released Global Vascular Guidelines and important new concepts emanating from these guidelines.
Parikh and colleagues discuss...
12/04/2019
Vascular Disease Management

Feature

Case Report
Multilevel CTO Crossing and Treatment
12/04/2019
Nagel and Adams describe a case that utilizes a personalized approach for access, crossing, and treatment in order to achieve the best outcomes for the patient.
Nagel and Adams describe a case that utilizes a personalized approach for access, crossing, and treatment in order to achieve the best outcomes for the patient.
Nagel and Adams describe a case...
12/04/2019
Vascular Disease Management
Original Research
Effect of Home-Based Exercise Training on Plasma Vascular Endothelial Growth Factor and Ankle-Brachial Index in Patients With Mild Peripheral Artery Disease: A Pilot Study
12/03/2019
Nurgroho and colleagues describe how home-based exercise training improved VEGF level and ABI in patients with PAD.
Nurgroho and colleagues describe how home-based exercise training improved VEGF level and ABI in patients with PAD.
Nurgroho and colleagues describe...
12/03/2019
Vascular Disease Management

Column

Editor's Corner
Prevention of PAD Must Be Our Goal
12/03/2019
Dr. Walker comments on a pilot study by Nugroho and colleagues, and how home-based exercise training may increase levels of VEGF in patients with mild PAD.
Dr. Walker comments on a pilot study by Nugroho and colleagues, and how home-based exercise training may increase levels of VEGF in patients with mild PAD.
Dr. Walker comments on a pilot...
12/03/2019
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

December 2019 Volume 12 Issue 16

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement